BACKGROUND: Our aim was to examine whether women who had a low number of retrieved oocytes at their ®rst IVF attempt reach the menopausal transition and/or the natural menopause earlier than women of similar ages with a high number of retrieved oocytes. METHODS: We conducted a retrospective cohort study among women in The Netherlands who received IVF treatment between 1983 and 1995. For the present study, we selected all cohort members who had a regular menstrual cycle at the time of the ®rst visit to the gynaecologist (n = 4601). After a median follow-up of 5.5 years, 3871 (84%) women still had a regular menstrual cycle pattern, 547 (12%) women had entered the menopausal transition (i.e. no menses for 3±11 months, use of HRT or irregular menstrual cycles) and 27 (1%) women had reached natural menopause. We examined whether the quantity and the quality of the retrieved oocytes were related to an early menopausal transition and early menopause. The live birth rate per embryo transfer was used as indicative of the quality of the oocytes. RESULTS: The age-adjusted odds ratio (OR) for having entered the menopausal transition/natural menopause for women with a poor response (0±3 oocytes) at their ®rst IVF attempt was 3.1 [95% con®dence interval (CI) 2.4±3.8] compared with women with a normal response (>3 oocytes). Women who were stimulated with gonadotrophins during IVF treatment but did not undergo an IVF puncture because of an anticipated poor response (cancelled IVF cycle) had an age-adjusted OR of 3.2 (95% CI 2.3±4.3). There was no signi®cant difference in the odds of reaching the menopausal transition/natural menopause, after adjustment for age and the number or retrieved oocytes, between women who did and did not have a live birth following their ®rst embryo transfer (OR = 1.3; 95% CI 0.95±1.7). CONCLUSIONS: These results indicate that a low remaining quantity of oocytes, as re¯ected by a low number of retrieved oocytes at ®rst IVF treatment, is an important predictor of the risk of an early menopausal transition/natural menopause. The quality of the oocytes did not affect the risk of an early menopausal transition/natural menopause once the number of retrieved oocytes had been taken into account. Our ®ndings support the concept that the number of remaining follicles in the ovaries is one of the main aspects of reproductive ageing.
Introduction
The ovarian concept of reproductive ageing assumes that the age-related loss in female fertility is dictated by the decline of both the quantity and the quality of the follicles (Te Velde and Pearson, 2002) . The years before the ®nal menstrual period, when variability in the menstrual cycle is increased, are known as the menopausal transition (WHO Scienti®c Group, 1996) . However, the de®nition of the menopausal transition remains vague since variability of the cycle was not de®ned. Recently, Mitchell et al. (2000) , Harlow et al. (2000a) and Soules et al. (2001) de®ned the menopausal transition based upon increasing variability and developed a staging system (Soules et al., 2001) within the time period of the menopausal transition (Soules et al., 2001) . Richardson et al. (1987) showed that in women with regular menstrual cycles (premenopausal), follicle counts were 10 times greater than in perimenopausal women of similar ages, while follicles were virtually absent in postmenopausal women.
Early ovarian depletion is likely to be re¯ected by a low number of retrieved oocytes (poor oocyte response) after gonadotrophin stimulation in IVF treatment. This is supported by the fact that in older women, fewer oocytes are retrieved after stimulation with gonadotrophins during IVF treatment than in younger women (Navot et al., 1991; Cahill et al., 1994; Seifer et al., 1999; Check et al., 2000) . Thus, a low number of retrieved oocytes after gonadotrophin stimulation for IVF would be expected to be associated with an earlier start of the menopausal transition. Indeed, in a small case±control study, we recently observed that the retrieval of a low number of oocytes at ®rst IVF treatment was associated with greater risk of early menopause (`46 years of age) (de Boer et al., 2002) .
In the present, much larger, study, we examine whether women who had a poor oocyte response at their ®rst IVF attempt enter the different menopausal transition stages earlier, or reach natural menopause earlier, than women of similar ages with a normal oocyte response. We also investigated whether poor quality of the retrieved oocytes is predictive of early menopausal transition or early natural menopause.
Materials and methods

Study population and study procedures
We conducted a retrospective cohort study of women who underwent IVF treatment in The Netherlands. The study populations, study procedures and data collection methods have been described in detail previously (Klip et al., 2001; de Boer et al., 2002) . Brie¯y, subjects are participants in a nationwide cohort study (the OMEGA-project) of 19 840 women treated with IVF in one of the 12 IVF clinics in The Netherlands between January 1, 1983 and January 1, 1995. The main purpose of the OMEGA study is to examine the risk of hormonerelated cancers in women who received hormone stimulation for IVF. All institutional ethics committees of the participating clinics approved the study procedures.
Between 1997 and 2000, all women received a questionnaire, an information letter and a study brochure. A total of 19 242 women received the 23-page study questionnaire, asking each participating subject for their written informed consent for data abstraction from the medical records. Seventy-three percent of the women returned the questionnaire. The upper part of Figure 1 displays a graphical presentation of the OMEGA study population.
Data collection
From the questionnaire, the following data were obtained: menopausal status, age at menopause, menstrual cycle characteristics, use of HRT, use of oral contraceptives (OCs), parity and smoking habits. In the questionnaire, women were asked to report their menstrual cycle characteristics referring to the time before their ®rst visit to the gynaecologist (1983±1995) and their current menstrual cycle characteristics (at completion of the questionnaire). Of particular relevance to the present study was the women's ability to predict the next menstrual cycle according to the following categories: always within 4 days; almost always within 4 days; mostly not within 4 days; never within 4 days; and not known, and one question concerning their mean menstrual cycle length: <21 days; 21±25 days; 26±30 days; 31±35 days; 36±42 days; >42 days; very irregular; and not known.
Furthermore, women were asked whether they used HRT for menopausal complaints, whether their menstrual cycle had ceased for 3±11 months prior to completion of the questionnaire and whether this was due to pregnancy/lactation or other reasons. In addition, women Relationship of response at ®rst IVF treatment to early menopause were also asked whether or not their last vaginal bleeding had occurred at least 12 months before completion of the questionnaire. Menopause was considered natural if it was not the result of (or possibly related to) surgery (hysterectomy, oophorectomy) or due to chemotherapy/ radiotherapy for cancer treatment.
Trained research assistants abstracted data from the medical ®les on: gynaecological history, subfertility diagnosis, fertility hormones used prior to IVF treatment, and detailed information about each subsequent IVF treatment (all fertility drugs and the corresponding dosages used during IVF treatment, the number of retrieved oocytes, occurrence of complications and whether or not the treatment resulted in a pregnancy).
Analytic cohort
To be eligible for the cohort study presented here, women had to have a regular menstrual cycle pattern at the time of their ®rst visit to the gynaecologist. Women were de®ned as having a regular menstrual cycle pattern when they were able to predict the next menstrual cycle always or almost always within 4 days and when their mean menstrual cycle length was between 21 and 35 days. Of all initial 10 215 IVFtreated women who returned the questionnaire and for whom medical record data were available, 6872 women reported to have had a regular menstrual cycle pattern at the time of the ®rst visit to the gynaecologist. The lower part of Figure 1 presents the distribution of the source population (n = 10 215) according to menstrual cycle characteristics and various exclusion criteria. Finally, 4601 women were eligible for the present study.
Subsequently, we examined whether, at the end of the follow-up period (at the completion of the questionnaire, follow-up time ranged from 0.5 to 16.2 years), women had kept their regular menstrual cycle pattern (premenopausal) or whether they had reached the menopausal transition or the natural menopause.
De®nitions of variables and methods of analysis
In the analysis, we compared the odds of having entered the menopausal transition or having reached natural menopause between women with a normal response and women with a poor response or a cycle cancellation due to insuf®cient follicle growth (anticipated poor response) at their ®rst IVF attempt. Type of response was taken as a proxy for oocyte quantity. By comparing only the number of retrieved oocytes at ®rst IVF treatment, and not at subsequent IVF attempts, the effects of previous ovarian stimulation and adaptation of stimulation regimens based on previous response experiences were largely avoided. Considering the number of retrieved oocytes and a mean fertilization rate of 50±60%, four oocytes are needed to reach an average of two embryos available for transfer (Bancsi et al., 2002) . Therefore, women who had`3 oocytes retrieved at their ®rst IVF attempt were de®ned as poor responders. Normal response was de®ned as the collection of >3 oocytes at the ®rst retrieval. Anticipated poor response was de®ned as an attempt at ovarian stimulation in women who eventually did not undergo an IVF puncture because of insuf®cient or no follicle growth. If the ®rst IVF cycle was cancelled due to risk of ovarian hyperstimulation syndrome (OHSS), the woman was included in the`normal responders' category (>3 oocytes). Furthermore, we examined the odds of having entered the menopausal transition or reaching the natural menopause according to the actual number of retrieved oocytes. However, when we used the number of oocytes as a continuous variable, we had to exclude those women whose ®rst cycle was cancelled because of insuf®cient or no follicle growth or risk of OHSS.
Subfertility diagnoses (based on medical record information) were divided into four categories: tubal (endometriosis included), male, unexplained subfertility (causes related to disturbances of the menstrual cycle included) and other or unknown subfertility causes. Each woman was categorized into only one category of subfertility diagnosis, i.e. the one which was assumed to contribute most to the subfertility. Duration of subfertility was determined by the period between start of involuntary childlessness and the date of ®rst visit to the IVF centre.
We categorized women into four different menopausal transition stages using somewhat arbitrary de®nitions based on the literature and the data that were available. We decided to de®ne women as having entered the menopausal transition when they were no longer able to predict the next menstrual cycle within 4 days while still having a mean menstrual cycle length of 21±35 days (`early' menopausal transition) (group a). For the subsequent`middle' stage of the menopausal transition, an additional criterion was a change in mean menstrual cycle length: women whose next menstrual cycle was not predictable within 4 days and who had a mean cycle length of <21 or >35 days (`middle' menopausal transition) (group b). Women whose menstrual cycle had ceased 3±11 months prior to the completion of the questionnaire (unless this was due to lactation/pregnancy or surgery such as hysterectomy) were categorized into the`late' menopausal transition (group c). Women who (had) used HRT for menopausal complaints were considered as a separate category because they could not be assigned to one of the stages of the menopausal transition (group d). Women whose last vaginal bleeding had occurred at least 12 months prior to the completion of the questionnaire (unless this was due to lactation/pregnancy or surgery such as hysterectomy, or due to chemotherapy/radiotherapy for cancer treatment) were considered as having reached the natural menopause. Women who considered themselves as post-menopausal but used HRT at that same time were included in the HRT subgroup. Women whose menstrual cycle pattern could not be categorized into either the premenopausal group, the various menopausal transition stages, natural menopause or HRT subgroup were categorized into the so-called`other' group.
Women were de®ned as smokers when they had smoked more than one cigarette a day for at least 1 year at the time of the ®rst oocyte retrieval.
The following three oocyte quality measures were used for the analyses of the results. Live birth rate (LBR) per started cycle, de®ned as any birth event in which at least one baby is born alive divided by the number of started IVF cycles (as a percentage), relates to the overall clinical effectiveness of the entire treatment cycle, including the ovarian response to stimulation, the ovum pick-up procedure, whether or not fertilization takes place, early embryonic development in vitro and the technique of the embryo transfer. The LBR per embryo transfer, which has the number of embryo transfers as denominator, is only related to the last phases of the treatment cycle which depend more directly on the oocyte quality. The ability of the embryo to implant into the uterus can also be regarded as a re¯ection of oocyte quality. It is de®ned by the number of gestational sacs visualized with ultrasound divided by the number of embryos replaced (Van Kooij et al., 1996) . Since this information was not available, we used the LBR per transferred embryo as a proxy of the implantation rate. The LBR per transferred embryo was de®ned as the number of babies born alive divided by the number of embryos replaced. For example, if the birth of a set of twins was the result of the transfer of two embryos, the LBR per embryo was 100%. If one child was born after four embryos had been transferred, the LBR per embryo was 25%. These examples demonstrate that several implantations may take place in one woman. These implantation successes cannot be taken as independent observations, a phenomenon known as overdispersion (Cox, 1970) . The Williams procedure (Williams, 1982) for dependency was used to correct for this phenomenon (Van Kooij et al., 1996).
All descriptive analyses were processed with SPSS â (version 10.0, SPSS Inc., Chicago, IL, USA). Because no normal distribution could be assumed, the comparison of the median number of retrieved oocytes between women who entered the menopausal transition or had reached natural menopause and women with a regular menstrual cycle pattern was analysed and tested by the Mann±Whitney U-test. Differences between group means and distributions over categories were tested by Student's t-test or c 2 test. A two-sided P-value <0.05 was considered statistically signi®cant.
We also estimated the age-speci®c prevalences of having reached the menopausal transition or natural menopause, for normal and (anticipated) poor responders separately. Three year age-speci®c moving averages were used for graphical presentation. The agespeci®c prevalence curve for the normal responders was based on the estimates between the ages of 29 and 46 years. For the poor and anticipated poor responders, the age-speci®c prevalence curve was based on the estimates between the ages of 35 and 48 years. All other age-speci®c prevalences were based on fewer than 50 women and were therefore omitted in the graphical presentation.
Multinomial logistic regression analysis was used to determine the odds ratios for having entered various stages of the menopausal transition or having reached natural menopause according to the number of retrieved oocytes at ®rst IVF treatment. Since we did not have information as to when women had entered the menopausal transition, the outcome used in the analysis was whether or not women had entered the various stages of the menopausal transition at the end of follow-up. Although we had information as to when women had reached the natural menopause, for reasons of comparability we used a uniform outcome measure and also determined whether or not women had reached the natural menopause according to the number of retrieved oocytes at ®rst IVF treatment. It is important to emphasize that our measure of disease occurrence is actually a prevalence measure instead of an incidence measure. Odds ratios, two-sided P-values, and 95% con®dence intervals (CIs) were calculated with a normal response at ®rst IVF treatment as the reference category. In a multivariate multinomial logistic regression model, it was determined whether or not it was necessary to adjust for potential confounders, such as the woman's age at time of ®lling out the questionnaire (continuous), the age at which the ®rst IVF treatment took place (3 years age groups), calendar year of IVF treatment (continuous), subfertility diagnosis (four categories), live birth after IVF (yes/no), smoking habits (yes/no and one category containing`unknown' smoking status), the number of IVF cycles per woman (continuous) and the number of ampoules of HMG/FSH used for ovarian stimulation during the ®rst IVF attempt (four categories). Potential confounders were evaluated by adding each confounder separately into the logistic model. If this resulted in a >10% change in the odds ratio (compared with the crude odds ratio), the confounder was included in the ®nal multinomial logistic model (Rothman and Greenland, 1998) . Table I presents cohort characteristics according to the type of response at the women's ®rst oocyte retrieval. Of all women, 80% had >3 oocytes at their ®rst oocyte retrieval (normal response), 14% had a poor response (`3 oocytes) and in 6% the ®rst IVF treatment was cancelled due to anticipated poor response. Women with a(n) (anticipated) poor response more often had their ®rst IVF treatment at an older age than women with a normal response. Consequently, both women who had a poor response and women with an anticipated poor response had a higher median age at the time of the completion of the questionnaire compared with normal responders. The LBR per started cycle, LBR per embryo transfer and the LBR per transferred embryo were signi®cantly higher among the normal responders than among the poor responders. Women with a(n) (anticipated) poor response less often had a live birth at or after their IVF attempt(s) compared with normal responders (39 and 34% versus 52%, data not shown). Poor responders and anticipated poor responders were more often smokers at the time of the ®rst oocyte retrieval than normal responders. After a median follow-up period of 5.5 years, 3871 (84%) women out of the cohort of 4601 women reported to have kept a regular menstrual cycle pattern, 547 (12%) had entered the menopausal transition and 27 (1%) had reached natural menopause. In addition, 156 (3%) women were categorized into the so-called`other' group. The latter group consisted of women who reported the predictability of their next menstrual cycle and/or their mean menstrual cycle length as`unknown' (n = 78), women who did not report their current menstrual cycle characteristics at all (n = 44) or women who reported a mean cycle length <21 or >35 days and yet reported being able to predict the next menstrual cycle within 4 days (n = 34). For women who had reached the menopausal transition/natural menopause, the median follow-up time was 6.6 years. The median number of retrieved oocytes at ®rst IVF treatment was signi®cantly lower for women who had entered the menopausal transition or had reached natural menopause compared with the women who still menstruated regularly (®ve and two versus eight, respectively).
Results
The menopausal transition group was divided into the following four tentative subgroups: (a) 209 (5%) were classi®ed in the`early' menopausal transition group; (b) 182 (4%) in the`middle' menopausal transition group; (c) 40 (1%) in the`late' menopausal transition; and (d) 116 (3%) women were categorized into the HRT subgroup. Apparently, few women had entered the`late' menopausal transition group or had reached natural menopause. Figure 2 presents the menstrual cycle characteristics at the end of follow-up according to type of oocyte response at ®rst IVF treatment. Figure 3 presents the age-speci®c prevalence rates for having reached the menopausal transition or natural menopause, for normal and (anticipated) poor responders separately. A comparison of the curves (i.e. the start of the slopes) suggests that poor and anticipated poor responders reach the menopausal transition/natural menopause~6±7 years earlier than normal responders. Table II presents the odds ratios for having entered one of the four different stages of the menopausal transition or natural menopause, according to the type of oocyte response at ®rst IVF treatment. All analyses were adjusted for age at completion of the questionnaire (continuous together with age squared) which was the only confounder according to our criteria. For women with a poor response and for women with an anticipated poor response, the odds ratios for having entered the`late' menopausal transition after a median of 5.5 years of follow-up were 5.0 and 7.4, respectively, compared with women with a normal response. The association between the number of retrieved oocytes at ®rst IVF treatment and thè early' menopausal transition was less strong, albeit signi®cant. The risk of having entered any of the stages of the menopausal transition was~3-fold elevated for women both with a poor and an anticipated poor response at their ®rst IVF attempt, as compared with women with a normal response. Poor and anticipated poor response were most strongly associated with the risk of reaching natural menopause in the 5±10 year period after the ®rst IVF treatment, with odds ratios of 14.6 and 17.5, respectively. When all menopausal transition categories and natural menopause were considered together, the odds ratios for reaching the menopausal transition/natural menopause for poor and anticipated poor responders were 3.1 (95% CI 2.4±3.8) and 3.2 (95% CI 2.3±4.3) respectively (data not shown). When we excluded from the analyses all women whose ®rst cycle was cancelled due to an anticipated poor response or due to an OHSS (n = 319) and included the actual number of retrieved oocytes in the multinomial regression model, the age-adjusted odds ratio for having entered the menopausal transition/natural menopause was 0.94 per additional oocyte retrieved (95% CI 0.92±0.96). This implies that for each additional oocyte retrieved at ®rst IVF treatment, the risk for entering the menopausal transition or reaching natural menopause in the subsequent 5±10 year period was 6% lower. Table III presents the overall odds ratios for having entered the menopausal transition (all three stages and HRT subgroup) combined with having reached natural menopause according to several characteristics. Women who smoked at the time of the ®rst oocyte retrieval were more likely to have entered the menopausal transition/menopause. Furthermore, we used the LBR per embryo transfer as indicative of the quality of the oocytes. Women who had no live birth following their ®rst embryo transfer had an increased risk, although not statistically signi®cant, to have reached the menopausal transition/natural menopause. However, when we also adjusted for the number of retrieved oocytes at ®rst IVF treatment (as a continuous variable), the odds ratio of reaching the menopausal transition/ natural menopause for women who had no live birth following their ®rst embryo transfer decreased from 1.4 to 1.3 (95% CI 0.95±1.7; data not shown). When we studied the separate and joint effects of oocyte response (proxy of quantity) and the occurrence of a live birth after embryo transfer (proxy for quality) on the risk of having entered the menopausal transition/natural menopause, no interaction effects between quantity and quality of the oocytes emerged (data not shown).
Discussion
Our ®ndings support the prevailing concept of female reproductive ageing, which assumes that the age-dependent loss of female fertility is dictated by the decline in both the quantity and quality of the oocyte/follicle pool. Women with a poor OR = odds ratio; CI = con®dence interval, from multinomial logistic regression. a`E arly' menopausal transition, mean menstrual cycle length 21±35 days and next menstrual cycle not predictable within 4 days;`middle' menopausal transition, mean menstrual cycle length <21 or >35 days and next menstrual cycle length not predictable within 4 days;`late' menopausal transition, no menses for 3±11 months prior to the completion of the questionnaire; HRT use. women who (had) used HRT for menopausal complaints; natural menopause, no menses for at least 12 months prior the completion of the questionnaire. b All four subgroups of the menopausal transition. c OR adjusted for age at completion of the questionnaire (continuous and age squared). d Normal response, >3 oocytes retrieved at ®rst IVF treatment or cycle cancellation due to OHSS; poor response, 0±3 oocytes retrieved at ®rst IVF treatment; anticipated poor response, cycle cancellation due to anticipated poor response. OR = odds ratio; CI = con®dence interval, from multinomial logistic regression. a All four subgroups of the menopausal transition and natural menopause combined. b Adjusted for age at the completion of the questionnaire (continuous and age squared).
Relationship of response at ®rst IVF treatment to early menopause response, or an anticipated poor response, at their ®rst IVF treatment are more likely to enter the menopausal transition or reach natural menopause in the next decade as compared with normal responders. The association between poor oocyte response and the risk of reaching the menopausal transition was stronger for the later stages of the menopausal transition and the natural menopause. These ®ndings are in line with a previous study in which we observed that (anticipated) poor responders are at greater risk of becoming post-menopausal at the age of 46 years or before, compared with normal responders (de Boer et al., 2002) . Women with a poor response were also found to have a lower LBR per transferred embryo, as indicative of poor oocyte quality (Table 1) , compared with normal responders. There was no signi®cant difference in the odds ratio of entering the menopausal transition/natural menopause between women who did and did not have a live birth following their ®rst embryo transfer. Our ®ndings provide convincing evidence for the quantitative aspect of the ovarian concept of female reproductive ageing. We also found that smokers at the time of the ®rst oocyte retrieval were more likely to have entered the menopausal transition or to have reached natural menopause. These ®ndings are in line with the literature, which consistently shows that smoking decreases menopausal age (Jick and Porter, 1977; McKinlay et al., 1992; Torgerson et al., 1994; van Noord et al., 1997; Harlow and Signorello, 2000) . In addition, women with a(n) (anticipated) poor response during their ®rst IVF attempt were more often smokers than women with a normal response. This observation is in line with studies which showed that cigarette smoke components might in¯u-ence oocyte quantity and quality directly or indirectly (Zenzes et al., 1995; Zenzes, 2000) .
De®ning the menopausal status of women is a dif®cult task for researchers and depends greatly on the source and completeness of the data. Many de®nitions of the menopausal status are based upon the work of Treloar (1981) and Vollman (1977) . Terms such as premenopause, perimenopause, climacteric, menopause and menopausal transition are often used in different ways and regularly create confusion. The World Health Organization (WHO Scienti®c Group, 1996) recommended the use of the terms premenopause, perimenopause and the menopausal transition. According to the WHO,`the menopausal transition is the time before the ®nal menstrual period when variability in the menstrual cycle is usually increased'. However, this de®nition remains vague since variability was not de®ned.
The criterion of`variability' or`predictability' is used in many studies de®ning menopausal status (Cooper and Baird, 1995; McKinlay, 1996; Harlow et al., 2000b; Mitchell et al., 2000; Gold et al., 2001) . Except for the study of Mitchell et al. (2000) and the STRAW workshop (Soules et al., 2001) , most of these studies lack any speci®c description of these terms. Brambilla et al. (1994) and Dudley et al. (1998) suggested that dif®culties in predicting the next menstrual cycle could be one of the early signs of approaching menopause. Furthermore, in several studies, the occurrence of amenorrhoea for 3±11 months is used as a criterion for the menopausal transition or late perimenopause (McKinlay et al., 1992; Brambilla et al., 1994; Guthrie et al., 1996; Dennerstein et al., 1997; Dudley et al., 1998; Harlow et al., 2000b; Gold et al., 2001) . In addition to the predictability of the next menstrual cycle and the mean cycle length, all participating women in the OMEGAproject were asked to report whether they used HRT. Since HRT in The Netherlands is nearly always prescribed to treat menopausal complaints, and not just to prevent osteoporosis during premenopause, we decided to include these women in the menopausal transition group. Since no questions were included in the questionnaire about the reasons for OC use, we were not able to distinguish women who used OCs for treating menopausal complaints. Therefore, women who used OCs 1 year prior the completion of the questionnaire (n = 978) and those with missing data on OC use (n = 181) were excluded from the analyses. To investigate the possibility of selection bias, we analysed the distribution of the oocyte response at ®rst IVF treatment in these excluded women. Of all the excluded women due to reasons of OC use (n = 1159), 78% had more than three oocytes at their ®rst oocyte retrieval (normal response), 16% had a poor response (three or fewer oocytes) and in 5% the ®rst IVF treatment was cancelled due to anticipated poor response. The percentages of (a)n (anticipated) poor and normal response are similar to those observed for the eligible women in our study, rendering selection bias unlikely.
One hundred and ®fty-six (3%) women were categorized into the so-called`other' group (i.e. menstrual cycle characteristics unknown). Women who had a poor response or anticipated poor response were more likely to have entered this group. We cannot exclude the possibility that the women in this subgroup who reported their menstrual cycle as unknown or did not report their menstrual cycle at all might actually have reached the menopausal transition or the natural menopause. Any resulting bias is likely to be small due to the small proportion of women concerned.
For the present study, we only selected cohort members who had a regular menstrual cycle at the time of the ®rst visit to the gynaecologist. Since our main interest was to study the women's reproductive ageing from cycle regularity to irregularity, in relation to the number of retrieved oocytes at the ®rst IVF attempt, we excluded women who had an irregular menstrual cycle at the ®rst visit to the gynaecologist. Furthermore, we used both the mean menstrual cycle length and the predictability to de®ne the regularity of the menstrual cycle at the time of the ®rst visit to the gynaecologist. We did so to avoid possible misclassi®cation, assuming that the reported mean menstrual cycle length would be less reliable if women were not able to predict their next menstrual cycle.
According to our results, the association between oocyte response and risk of entering the menopausal transition after a median follow-up of 5.5 years was stronger for the later stages of the menopausal transition and for the natural menopause. While poor responders at ®rst IVF treatment had a 15-fold increased risk of natural menopause, their risk of entering the early menopausal menopausal transition was only 2-fold increased. When we considered women in the`early' menopausal transition as premenopausal, the age-adjusted odds ratios for having entered the menopausal transition/natural menopause for poor and anticipated poor responders increased to 3.9 (95% CI 3.0±5.1) and 4.3 (95% CI 3.1±6.1) respectively, as compared with normal responders at their ®rst IVF treatment. Misclassi®cation of menopausal transition according to the current menstrual cycle pattern is less likely to have occurred for women who were categorized into the`middle' and`late' menopausal transition. Many aspects of the female reproductive ageing process are not well understood, and it remains dif®cult to design a classi®cation system which is adequate and widely applicable. It is indeed not certain whether less predictability of the menstrual pattern is the ®rst sign of the menopausal transition, as we assumed in the de®nition of early menopausal transition.
By comparing only the number of retrieved oocytes at ®rst IVF treatment, and not at subsequent IVF attempts, most of the effects of previous ovarian stimulation and adaptation of stimulation regimens based on previous response experiences were avoided. However, in The Netherlands, stimulation regimes for IVF treatment have changed over the past years and women might, before they underwent IVF treatment, already have received gonadotrophin stimulation followed by intrauterine insemination, after which the stimulation protocols for IVF treatment might have been adapted. Therefore, we added the number of ampoules of HMG/FSH used during IVF treatment and year of IVF treatment as possible confounders in the multinomial logistic regression analyses. Both possible confounders did not change our risk estimates by more than 10% and were therefore not included in the ®nal multinomial logistic regression analysis.
When interpreting our results, the strengths and limitations of the study design need to be considered. For 3227 IVF-treated women (Figure 1 ) participating in the OMEGA-project who returned the questionnaire, data from the medical ®les could not yet be obtained. Since this was due to limited project funding resulting in a random sample of records not yet completed, it is highly unlikely that this has led to selection bias. With respect to selection bias due to non-response to the mailed questionnaire, the following information is useful. From an anonymous sample of the non-responding women (n = 1672), we abstracted data from the medical ®les. Of the non-responding women to the OMEGA questionnaire, 72% had a normal oocyte response at their ®rst IVF attempt, 19% had a poor response and 9% had an anticipated poor response. The percentages of (anticipated) poor responders among the non-responding women are somewhat higher than those found in the present study. These results suggest that women with a low response or an anticipated poor response at their ®rst IVF attempt (and therefore a lower probability of having a live birth) were less inclined to participate. However, non-response bias could only have occurred if non-responding women who had a(n) (anticipated) poor response would also have entered the menopausal transition more or less frequently than responding women. We investigated this in a group of 213 women who initially did not respond to the OMEGA questionnaire, but who eventually did respond after a phone call. In this group of women, the percentages across oocyte response categories (75% normal response, 16% poor response and 10% anticipated poor response) were very similar to those of women who persisted in non-response also after a telephone call. Reassuringly, the age-adjusted odds ratios for reaching the menopausal transition/natural menopause were comparable with those for the total group of responders, 1.8 (95% CI 0.6±5.0) for a poor oocyte response and 2.9 (95% CI 0.9±9.0) for anticipated poor response. This ®nding renders selection bias unlikely.
Furthermore, since in the OMEGA questionnaire information on menstrual cycle characteristics was collected retrospectively, women might have been misclassi®ed according to their menstrual cycle pattern. However, we would expect the proportion of misclassi®ed women to be the same among those with a normal response and a(n) (anticipated) poor response. This so-called non-differential bias would have attenuated the observed risk estimates.
In conclusion, our results indicate that women with a low number of retrieved oocytes at ®rst IVF treatment have an increased risk of reaching the menopausal transition or natural menopause in the decade after the ®rst IVF treatment.
